When.com Web Search

  1. Ads

    related to: occc oncologists with treatment experiences

Search results

  1. Results From The WOW.Com Content Network
  2. My Rare Cancer Has Recurred 3 Times in 3 Years. At Age ... - AOL

    www.aol.com/rare-cancer-recurred-3-times...

    My oncologist was very goal-oriented during the phone call where he went over the results of the biopsy. He was like, "OK, here's what we're going to do next. This is what's happening, and this is ...

  3. Woman, 34, says doctors ‘brushed off’ her symptoms. She had ...

    www.aol.com/news/woman-34-says-doctors-brushed...

    After her experience, Campbell and her husband founded an organization Not These Ovaries to raise money to fund screening for ovarian cancer and developing a treatment. There's currently no ...

  4. I Aged 20 Years In Just 2 Weeks After Being Treated For A ...

    www.aol.com/aged-20-years-just-2-132251893.html

    “These two treatments will push you into menopause,” my oncologist informed me, as if he was explaining a simple math equation. “You may or may not experience symptoms.” “OK,” I responded.

  5. Sudeep Gupta - Wikipedia

    en.wikipedia.org/wiki/Sudeep_Gupta

    Dr Sudeep Gupta receiving a research grant . Dr Sudeep Gupta, born February 8, 1969, is an Indian medical doctor and medical oncologist, currently serving as the Director of the Tata Memorial Centre (TMC), a unit of the Department of Atomic Energy, Government of India.

  6. Jeffrey Long - Wikipedia

    en.wikipedia.org/wiki/Jeffrey_Long

    Jeffrey Long is an American author and researcher into the phenomenon of near-death experiences (NDEs). A physician by training, Long practices radiation oncology at a hospital in Kentucky. Long is the author of Evidence of the Afterlife: The Science of Near-Death Experiences, which appeared on The New York Times Best Seller list. In 1998, he ...

  7. Cancer of unknown primary origin - Wikipedia

    en.wikipedia.org/wiki/Cancer_of_unknown_primary...

    This view is widely accepted in oncology; in fact, these cancers are also referred to as occult primary tumors. Because the site of the primary tumor usually dictates the treatment and expected outcome, this view may help create uncertainty and anxiety among health professionals and patients, who may feel that their evaluation has been incomplete.